AlphAIAlphAI — Financial news for AI agents
TradingViewMAY 182 min read$FBIOP

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

This article provides details about Fortress Biotech, Inc.'s 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) on the Nasdaq Stock Market. It briefly mentions the availability of financial data, news, community insights, and technical analysis for this specific stock. The content seems to be a snapshot of a financial data platform's entry for FBIOP, showing it's publicly traded and offers various analytical tools.

Original reporting
TradingView
Published May 18, 2026, 5:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 18, 2026, 6:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock — source image
Source · TradingView
Decision brief

The 30-second read

$FBIOPNeutralLow
01

Why it matters

Current data suggests minimal immediate impact on trading strategies.

02

Market read

The stock has low relevance to broader market movements but may be of interest to specialized investors.

03

What to watch

Potential upcoming corporate actions or market shifts could alter the stock's relevance or impact.

Timing: low

Background

Fortress Biotech's preferred stock FBIOP is a niche financial instrument with limited trading activity.

Company-level read

Ticker impact

$FBIOPNeutralMedium confidence
Context

This is a preferred stock of Fortress Biotech with limited trading volume and low relevance to the broader market.

Expected impact

Likely negligible short-term price movement; long-term impact depends on Fortress Biotech's overall performance.

Evidence & confidence

Limited trading volume and niche status reduce the likelihood of significant price swings based solely on this information.

Market effects

Sector

Limited sector impact due to the specialized nature of preferred stocks.

Regional

Minimal regional influence; primarily relevant to existing shareholders and niche investors.

Global

Negligible

Counterpoint

What could challenge this read

If Fortress Biotech's financial health improves significantly, FBIOP could become more attractive, warranting a reevaluation.

Key entities

  • Company
    Fortress Biotech, Inc.

    A biotechnology company listed on Nasdaq.

Read at source← All news

Related articles

SEP 17
$DASHMed

DoorDash and Uber eats nationwide delivery services from Costco

Costco partners with DoorDash for nationwide U.S. delivery, expanding from select international markets. Only Costco members linking accounts can use the service. Costco has 81M members and 639 U.S. stores. Instacart has offered delivery for about a decade. Earlier in 2024, Costco also partnered with Uber Eats, which has since expanded nationwide.

sjvsun.com2 min
SEP 17
$LMTMed

LMT Looks 4.5% Undervalued on GF Value™ with Strong Dividend App

Lockheed Martin (LMT) secured a $234.46M contract modification for 16 UH-60M Black Hawk helicopters, raising the total contract value to $356.25M. The company offers a 2.55% dividend yield, a 50% payout ratio, and a 3-year dividend growth rate of 5.4%. LMT's GF Score™ is 80/100, with strengths in profitability and valuation. Institutional activity shows mixed sentiment, with 21 premium gurus holding shares. The stock is trading 4.5% below its GF Value™ of $563.60, at $538.09.

gurufocus.com2 min
SEP 17
$UBERLow

Uber Technologies sells $182.2m of Aurora Innovation stock

Uber sold 29.4 million shares of Aurora Innovation (AUR) for $182.2 million at $6.205 per share, reducing its stake to 157.1 million shares. Aurora's Q2 2026 earnings showed a wider-than-expected loss of $0.14 per share but higher revenue of $2 million. The stock has surged 54% in six months, though it may be overvalued according to InvestingPro analysis.

investing.com2 min
SEP 17
$LMTHighAI 8/10

LMT Looks 4.5% Undervalued on GF Value™ with Strong Dividend Pro

Lockheed Martin (LMT) secured a $234.46M contract modification for 16 UH-60M Black Hawk helicopters, increasing the total contract value to $356.25M. The company offers a 2.55% dividend yield, a 50% payout ratio, and a 3-year dividend growth rate of 5.4%. LMT's stock is 4.5% undervalued relative to its GF Value™ of $563.60, with a GF Score™ of 80/100. Institutional investors show confidence, while insiders have sold $4.0M worth of shares in the past year.

gurufocus.com3 min